ArticleActa pharmaceutica Sinica. B2021

Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for

Yamin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.